sarpogrelate has been researched along with Interstitial Nephritis in 1 studies
sarpogrelate: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamasaki, Y | 1 |
| Doi, K | 1 |
| Maeda-Mamiya, R | 1 |
| Ogasawara, E | 1 |
| Katagiri, D | 1 |
| Tanaka, T | 1 |
| Yamamoto, T | 1 |
| Sugaya, T | 1 |
| Nangaku, M | 1 |
| Noiri, E | 1 |
1 other study available for sarpogrelate and Interstitial Nephritis
| Article | Year |
|---|---|
A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.
Topics: Adenine; Animals; Cells, Cultured; Disease Models, Animal; Fatty Acid-Binding Proteins; Fibrosis; In | 2013 |